Oral quinolones versus intravenous β-lactam for the treatment of acute focal bacterial nephritis: a retrospective cohort study.
L AceitunoA Nuñez-CondeJ Serra-PladevallB ViñadoE CastellaLaura Escolà-VergéC PigrauV FalcóY O LenPublished in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)
When susceptible, treatment of AFBN with oral quinolones is as effective as IV β-lactam treatment with fewer adverse events.